PRKN and Parkinson disease: Furthermore, it is critical to note that many of the specific molecular mechanisms discussed, particularly those in section 5.2 regarding mitochondrial homeostasis (e.g., PINK1/Parkin and PGC-1α pathways), are extrapolated from preclinical models of other diseases (such as Parkinson’s, stroke, or diabetes).